PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26517938-1	2016	Brassinosteroid (BR) binding activates the receptor kinase BRI1 by inducing heterodimerization with its co-receptor kinase BAK1; however, the mechanisms that reversibly inactivate BRI1 remain unclear.	Brassinosteroids	0-15	BCL2 antagonist/killer 1	Homo sapiens	123-127	
26802250-5	2016	Further analyses indicated that TWD1 modulates the BR signal transduction not by altering ER quality control or protein abundance of BRI1; instead, TWD1 appears to be critical in BR-induced interaction of BRI1 and its co-receptor BAK1, as well as BR-induced phosphorylation of these two proteins.	Brassinosteroids	51-53	BCL2 antagonist/killer 1	Homo sapiens	230-234	
26517938-1	2016	Brassinosteroid (BR) binding activates the receptor kinase BRI1 by inducing heterodimerization with its co-receptor kinase BAK1; however, the mechanisms that reversibly inactivate BRI1 remain unclear.	Brassinosteroids	17-19	BCL2 antagonist/killer 1	Homo sapiens	123-127	
24308570-5	2013	Genetic and structural analyses indicated that BAK1 and its homologs play indispensible roles in mediating brassinosteroid (BR) signaling pathway by directly perceiving the ligand BR and activating the receptor of BR, BRI1.	Brassinosteroids	107-122	BCL2 antagonist/killer 1	Homo sapiens	47-51	
19704566-1	2008	BAK1 and BKK1 are two functionally redundant leucine-rich repeat receptor-like protein kinases (LRR-RLKs) involved in brassinosteroid signal transduction by their direct interactions with the BR receptor, BRI1.	Brassinosteroids	118-133	BCL2 antagonist/killer 1	Homo sapiens	0-4	
19748302-3	2009	Since its first description in 2001, several independent groups have discovered BAK1/SERK3 as a component of diverse processes, including brassinosteroid signaling, light responses, cell death, and plant innate immunity.	Brassinosteroids	138-153	BCL2 antagonist/killer 1	Homo sapiens	80-84	
19532123-0	2009	Membrane steroid-binding protein 1 (MSBP1) negatively regulates brassinosteroid signaling by enhancing the endocytosis of BAK1.	Brassinosteroids	64-79	BCL2 antagonist/killer 1	Homo sapiens	122-126	
18694562-0	2008	Sequential transphosphorylation of the BRI1/BAK1 receptor kinase complex impacts early events in brassinosteroid signaling.	Brassinosteroids	97-112	BCL2 antagonist/killer 1	Homo sapiens	44-48	
18694562-1	2008	Brassinosteroids (BRs) regulate plant development through a signal transduction pathway involving the BRI1 and BAK1 transmembrane receptor kinases.	Brassinosteroids	0-16	BCL2 antagonist/killer 1	Homo sapiens	111-115	
18694562-1	2008	Brassinosteroids (BRs) regulate plant development through a signal transduction pathway involving the BRI1 and BAK1 transmembrane receptor kinases.	Brassinosteroids	18-21	BCL2 antagonist/killer 1	Homo sapiens	111-115	
18694562-3	2008	We demonstrate that BR-dependent activation of BRI1 precedes association with BAK1 in planta, and that BRI1 positively regulates BAK1 phosphorylation levels in vivo.	Brassinosteroids	20-22	BCL2 antagonist/killer 1	Homo sapiens	78-82	
16699538-3	2006	Recent studies have demonstrated that BR binding to the extracellular domain of BRI1 induces kinase activation and dimerization with another receptor kinase, BAK1.	Brassinosteroids	38-40	BCL2 antagonist/killer 1	Homo sapiens	158-162	
33964457-4	2021	Using the RiD-receptors, we demonstrated that the rapamycin-mediated association of chimeric cytosolic kinase domains from the BRI1/BAK1 receptor/co-receptor, but not the BRI1/BRI1 or BAK1/BAK1 homodimer, is sufficient to activate downstream brassinosteroid signaling and physiological responses and that the engineered RiD-FLS2/BAK1 activates flagellin-22-mediated immune signaling and responses.	Brassinosteroids	242-257	BCL2 antagonist/killer 1	Homo sapiens	132-136